story of the week
Impact of GLP-1 Receptor Agonist–Based Treatments on Fat-Free Mass
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Glucagon-like peptide-1 receptor agonist-based agents and weight loss composition: Filling the gaps
Diabetes Obes Metab 2024 Sep 30;[EPub Ahead of Print], RL Dubin, SB Heymsfield, E Ravussin, FL GreenwayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.